Blog: Patient Insights & Thought Leadership

Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.

Two female Healthcare Professionals (HCPs) in lab coats reviewing glowing digital data and medical information on a screen, demonstrating a modern, high-tech approach to community and collaboration

Building a Better Bridge: Why a Dedicated Community is the Future of HCP Engagement

October 7, 2025

In the battle for HCP attention, the loudest voice doesn't win—the most trusted one does.

The Missing Link: Marrying Clinical Data with Patient Insights

September 30, 2025

Discover how connecting hard data with human experience is the key to unlocking richer provider-patient conversations and stronger brand advocacy.

A Catalyst for Connection: How a Crackdown on DTC Ads Could Transform Pharma Ads to Better Serve Patients

September 24, 2025

The future of health advertising belongs to thoughtful, digitally-driven, opted-in media and specialized content that prioritizes patient education and advocacy above all else.

Beyond the Status Quo: Why HCPs Need Content Delivered Differently

September 22, 2025

Your current content strategy is likely failing to reach overwhelmed HCPs—here's why and how to adapt.

IBS Patient-Reported Survey Data 2020

October 19, 2020

Merely 9% of people living with IBS were currently taking a prescription IBS medication, according to new Health Union patient-reported survey data.

Alzheimer’s Disease Patient-Reported Survey Data | 2020

October 6, 2020

Only 11% of people living with Alzheimer’s disease feel controlled on their current treatment plan, according to Health Union patient-reported survey data.

COPD Patient-Reported Survey Data | 2020

September 23, 2020

44% of people living with COPD who experience pain consider themselves as having chronic pain, according to new Health Union survey data.

Multiple Sclerosis Patient-Reported Survey Data | 2020

September 10, 2020

71% of people living with multiple sclerosis currently use a DMT but many live with pain and emotional grief, according to new Health Union survey data.

Healthcare Industry Thought Leadership

Contact